Jul 11, 2025 | Comparative Effectiveness, Cost Savings, Drug costs, Evidence-based research, Formularies, High-value formulary, MedBen Rx, Rx Advertising, Rx Costs, Rx prices, Rx Spending
Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about...
Jul 1, 2025 | Benefits preservation, Diabetes, GLP-1s, MedBen Rx, Ozempic, Rebates, Specialty Drugs, Spread Pricing, Transparency, Wegovy, Weight loss, Weight loss drugs
The 2025 Milliman Medical Index confirms what many employers are seeing firsthand: prescription drug costs are rising faster than any other health care expense, with a 9.7% increase over the past year. To help employers reclaim their drug spend, MedBen Rx offers a...
Jun 16, 2025 | Drug costs, Pharmacies, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs
A recent Statista article examines the disparity in prescription drug spending across countries. The Organisation for Economic Co-operation and Development (OECD) ranks the United States highest in average spending, at $1,218 per resident – over $200 more than...
May 19, 2025 | Biosimilar, Cancer, Drug costs, Generic Drugs, GLP-1s, Rx Costs, Study
Prescription drug spending in the U.S. climbed 10.2% in 2024, reaching nearly $806 billion, according to a report from the American Society of Health-System Pharmacists. A significant portion of this growth is attributed to the rapid rise of...
May 5, 2025 | Legislation, News, Pharmacies, Pharmacy Benefits Manager (PBM), State legislation
On April 16, Arkansas became the first state to ban pharmacy benefit managers (PBMs) from acquiring an interest in – or otherwise directly or indirectly holding a permit for the retail sale of – prescription drugs, including mail-order...
